Covid-19: See latest data on suppliers and inventory

MODERNA logo

MODERNA

PSF Verified
200 Technology Square, Cambridge, MA 02139, United States
Moderna, Inc develops messenger RNA therapeutics. It provides in vivo drug modality that produces human proteins or antibodies inside patient cells. Moderna Therapeutics also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. It focuses on disease areas, such as inherited genetic disorders, hemophilia and blood factors, and oncology. It has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals an...
DUNS #:
069723520
CAGE Code:
6RP85
Type:
Manufacturer
Employees:
500-1,000
Annual Revenue:
$50M-$100M
Year Founded:
2010
Country of Origin:
United States
Sectors Served:
US Federal, Private Sector
Company Security Level:
Unknown
Credit Card Usage:
Unknown

Specialties and Expertise:

Biotechnology, Genetics, Health Care, Medical, Pharmaceutical, mRNA, Messenger RNA Technology, mRNA Medicines, Messenger Ribonucleic Acid, Protein Synthesis, mRNA Technological Solutions, mRNA Prop...

Contact Info2

Size and minority status

Size
Other than small business
Ownership
African American
Alaska Native
Asian-Indian
Asian-Pacific
Hispanic
Minority-Unspecified
Native American
Native Hawaiian
Tribal
Unspecified
Veteran
Woman
Government Set-Aside Programs
AbilityOne
HUBZone
SBA 8(a)
SDVOSB
Small Disadvantaged Business (SDB)
Woman Owned Small Business (WOSB)

Commodity Codes6

PRODUCTS AND SERVICES4

mRNA Technological Solutions
Moderna uses mRNA technological solutions to create new medicines/vaccines such as Prophylactic vaccines, Cancer vaccines, Intratumoral immuno-oncology, Localized regenerative therapeutics, Systemic secreted & cell surface therapeutics.
mRNA Technology
1 past experience
mRNA works in protein synthesis by transferring the instructions stored in DNA to make the proteins required in every living cell that could prevent, treat, or cure diseases. mRNA technology is used to manufacture mRNA medicines.
mRNA Prophylactic Vaccines
2 past experiences
Moderna’s Prophylactic Vaccines Modality is to prevent or control infectious diseases. Currently, this modality has development candidates against viruses for commercial and potential global health uses.
mRNA-1273
1 past experience
National Institutes of Health (NIH) and Moderna’s infectious disease research team has started working on the development of vaccine mRNA-1273 to fight against the novel coronavirus.

Past experience3

other
Novel Coronavirus (2019-nCoV) Vaccine Devel...
Moderna and Coalition for Epidemic Preparedness Innovations (CEPI) are on the development of mRNA vaccine against the novel coronavi...
other
Prophylactic Vaccines Modality for Commerci...
Moderna’s Prophylactic Vaccines Modality currently has five development candidates for commercial uses that include respiratory sync...
other
Prophylactic Vaccines Modality for Global H...
Moderna’s Prophylactic Vaccines Modality has three development candidates for potential global health uses including influenza H10N8...

External Recognition1

A Top Employer
Moderna named in the list of top biopharma industry employers for the past four years.
2018

Locations served1

  • United States 1 location
My Notes
Contact
My Notes